[Abstract] Primary neurons represent an ideal cellular system for the identification of therapeutic oligonucleotides for the treatment of neurodegenerative diseases. However, due to the sensitive nature of primary cells, the transfection of small interfering RNAs (siRNA) using classical methods is laborious and often shows low efficiency. Recent progress in oligonucleotide chemistry has enabled the development of stabilized and hydrophobically modified small interfering RNAs (hsiRNAs). This new class of oligonucleotide therapeutics shows extremely efficient self-delivery properties and supports potent and durable effects in vitro and in vivo. We have developed a high-throughput in vitro assay to identify and test hsiRNAs in primary neuronal cultures. To simply, rapidly, and accurately quantify the mRNA silencing of hundreds of hsiRNAs, we use the QuantiGene 2.0 quantitative gene expression assay. This high-throughput, 96-well plate-based assay can quantify mRNA levels directly from sample lysate. Here, we describe a method to prepare short-term cultures of mouse primary cortical neurons in a 96-well plate format for high-throughput testing of oligonucleotide therapeutics. This method supports the testing of hsiRNA libraries and the identification of potential therapeutics within just two weeks. We detail methodologies of our high throughput assay workflow from primary neuron preparation to data analysis. This method can help identify oligonucleotide therapeutics for treatment of various neurological diseases.
drug screening, providing more relevant in vivo biological information than biochemical assays and reducing the need for animal testing. High-throughput assays performed in primary neurons have emerged as a powerful tool to discover new therapies for the treatment of neurodegenerative disorders, such as Huntington's disease (HD), amyotrophic lateral sclerosis (ALS) or Alzheimer's disease (AD) (Sharma et al., 2012) . Cell based assays using primary neurons provide a more natural (relevant) environment for studying neurodegenerative disorders than clonal neuronal lines. Transfecting oligonucleotide-based therapeutics into primary neurons generally relies on approaches such as electroporation (Mertz et Our laboratory has established a rapid high-throughput platform to identify and validate hsiRNA leads in primary neurons in vitro in 96-well format. To quantify the amount of target mRNA upon hsiRNA treatment, we use the QuantiGene 2.0 branched DNA (bDNA) assay, a high-throughput, 96-well platebased mRNA quantification assay. This technique is designed to directly quantify the target mRNA from sample lysate without the need to purify the RNA, thus minimizing sample manipulation (Kern et al., 1996; Coles et al., 2015) . This assay enables accurate and precise detection of even low abundance mRNAs, minimizing experimental variability and error (Collins et al., 1997; Canales et al., 2006) . The combination of both self-delivering hsiRNAs and high-throughput quantification of mRNA accelerates the identification of efficacious oligonucleotides in primary neurons.
Here, we describe the workflow of this high throughput assay for performing large-scale screening and dose response validation of hsiRNAs in primary cortical neurons. We detail our methods for primary cortical neuron preparation in 96-well plate format (Figure 2 ), neuronal treatment with hsiRNA, assay plate management, mRNA quantification, and data analysis. This platform can be used for the screening of oligonucleotide therapeutics in primary neurons for the potential treatment of neurodegenerative diseases. To coat the plates, transfer 100 μl of 0.01% poly-L-lysine to each well using a multichannel micropipette.
Poly-L-lysine (
2. Incubate overnight in the tissue culture incubator at 37 °C.
3. The next day, before the dissection, aspirate the coating solution using a vacuum-connected
Pasteur pipet (or a 200 μl multichannel micropipette) and rinse three times with 100 μl PBS.
4. Remove the final wash and let the plate dry in the biological safety cabinet.
www.bio-protocol.org/e2501 4. Place the embryonic sacs in a 10 cm dish containing 10 ml of ice-cold DMEM.
5. Using microscissors and forceps, carefully open the embryonic sacs, remove the embryos and transfer to a 10 cm dish containing 10 ml of ice-cold DMEM.
Note: Steps C6 to C10 are performed one embryo after another.
6. Place the forceps near the back of the embryos skull and pull forward toward the nose.
7. Place the forceps on either side of the head, beneath the brain, and carefully lift the brain out of the skull (Video 1).
Video 1. Removal of the brain from the skull
www.bio-protocol.org/e2501 10. Under a dissecting microscope, use forceps to carefully peel away the meninges from the upper surface of each brain hemisphere. The cortex will fall away from the brain after the meninges are removed ( Figure 3B ).
11. Using the forceps, carefully separate the cortices from the brain. 14. Place the tube upright for a few minutes to allow the cortices to sediment at the bottom of the tube.
15. Without disturbing the cortices, slowly and carefully remove the papain/DNase solution using a 1 ml micropipette (be sure to remove as much papain/DNase solution as possible) and add 1 ml of plating medium. 25. Incubate the plates overnight at 37 °C, 5% CO2 in a tissue culture incubator.
26. The following day, using a multichannel micropipette, slowly add 100 μl of feeding medium (containing anti-mitotics) to each well to prevent the growth of non-neuronal cells. Be careful not to disturb the cells.
27. Every 3-4 days, replace half of the volume of media with freshly prepared feeding medium.
Using a multichannel micropipette, slowly remove 100 μl of medium from each well without touching the bottom of the well to avoid disturbing the cells. Very gently, add back 100 μl of freshly prepared and pre-warmed feeding medium without disturbing the cells. E. mRNA quantification mRNA is quantified using the QuantiGene 2.0 bDNA Assay (Affymetrix). All the volumes used in the following steps are for one plate. Prepare all the solutions used for this procedure in clean 50 ml conical tubes using clean serological pipettes.
1. In a 50 ml conical tube, prepare the diluted lysis mixture (DLM; 1:2 v/v, lysis mixture/water, e.g., 10 ml lysis mixture:20 ml water) complemented with 100 μl of 50 μg/μl Proteinase K (provided with the kit) and pour it into a 50 ml reservoir. Diluted lysis mixture should be prepared fresh for every experiment. Storing the diluted lysis mixture in the fridge will cause precipitate to form.
2. Remove all growth medium from the plate. Housekeeping and target genes may require different volumes of lysate in the same experiment.
9. Top off each well to 100 μl with DLM (no Proteinase K).
10. Seal the plate very tightly with an aluminum plate seal (provided with the kit) and centrifuge for 1 min at 240 x g at room temperature.
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Data analysis
Note: Data are processed using Microsoft Office Excel and analyzed using GraphPad Prism 7 software. [(
5. If compounds are tested in replicate, average the replicates and calculate the standard deviation.
6. For dose response analysis, graph concentration-dependent IC50 curves using a non-linear regression curve fit, log(inhibitor) vs. response-variable slope (four parameters). If necessary, set the lower limit of the curve at zero, and the upper limit of the curve at 100. 2. Cells should show signs of making neurites by two hours after plating. If they are still round without neurites on the second day, they will probably not grow. 
